Results 211 to 220 of about 63,634 (227)

The OPAT opportunity for beta-lactam individualization. [PDF]

Antimicrob Steward Healthc Epidemiol
Childs-Kean LM, Rivera CG, Venugopalan V, Johnson MJ, Barreto EF.   +4 more
europepmc   +1 more source

Characterization of YdgH: a mediator of beta-lactam susceptibility in Enterobacterales. [PDF]

Microbiol Spectr
Lazarus JE, Waldor MK, Hooper DC.
europepmc   +1 more source

Copy number flexibility facilitates heteroresistance to increasing antibiotic pressure and threatens the beta-lactam pipeline. [PDF]

Nat Commun
Choby JE, Ozturk T, Abbott CN, Nnabuife C, Colquhoun JM, Satola SW, Rather PN, Palzkill T, Weiss DS.   +8 more
europepmc   +1 more source

Ertapenem Combined With Anti-<i>Staphylococcal</i> Beta-Lactam Therapy for the Treatment of Persistent <i>Staphylococcus Aureus</i> Bacteremia in a Child With Vertebral Osteomyelitis. [PDF]

J Pediatr Pharmacol Ther
Shirley DA, Gutierrez L, Vuong L, Moonah S.   +3 more
europepmc   +1 more source

Serum Concentration at 24 h With Intensive Beta-Lactam Therapy in Sepsis and Septic Shock: A Prospective Study: Beta-Lactam Blood Levels in Sepsis. [PDF]

Crit Care Res Pract
Thériault E, Benali M, Starnino S, Blain H, Goettel N, Beloin-Jubinville B, Marsot A, Lamontagne F.   +7 more
europepmc   +1 more source

Continuous or extended vs intermittent infusions of beta-lactam antibiotics in ICU patients with pneumonia: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Antimicrob Agents Chemother
Li Y, Roberts JA, Abdul-Aziz MH, Sime FB.   +3 more
europepmc   +1 more source